Your browser doesn't support javascript.
loading
Acute idiopathic maculopathy after COVID-19 vaccination.
Hasegawa, Taiji; Sannomiya, Yoka; Toyoda, Momoka; Maruko, Ichiro; Iida, Tomohiro.
Affiliation
  • Hasegawa T; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
  • Sannomiya Y; Department of Ophthalmology, The Second Shiseikai Hospital, Tokyo, Japan.
  • Toyoda M; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
  • Maruko I; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
  • Iida T; Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
Am J Ophthalmol Case Rep ; 26: 101479, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35282606
ABSTRACT

Purpose:

We report a case of acute idiopathic maculopathy (AIM) that developed after COVID-19 vaccination. Observations A 54-year-old woman complained of a sudden decrease of visual acuity in her right eye one day after receiving a second COVID-19 vaccination (Pfizer). Fundus photograph showed a circular yellow lesion at the fovea in right eye. Optical coherence tomography revealed the thickening of retinal pigment epithelium and the presence of subretinal fluid. Three months after the initial visit, the BCVA and the fundus images had favorable recovery in the right eye. Conclusions and Importance We describe a case of AIM after receiving COVID-19 vaccination. These findings may be a helpful in understanding the pathogenesis of AIM.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Ophthalmol Case Rep Year: 2022 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Ophthalmol Case Rep Year: 2022 Document type: Article Affiliation country: Japan